Nutraceutix, Inc. Licenses Subsidiary of Boehringer-Ingelheim to Market Calcium D-Glucarate
REDMOND, Wash.--(BW HealthWire)--April 3, 2000--Nutraceutix, Inc. (OTC BB:NUTX - news) a Redmond, Washington based company, has licensed Quest Vitamins, a subsidiary of Boehringer-Ingelheim, (Canada) Ltd. the non-exclusive right to distribute health supplement products containing the patented dietary supplement compound, Calcium D-Glucarate(TM).
Boehringer Ingelheim group, is one of the world's 20 leading pharmaceutical corporations -- with products focused on human pharmaceuticals (prescription, hospital and self-medication) as well as animal health.
Quest Vitamins, based in Burlington, Ontario, Canada, markets and distributes sports, diet, herbal and specialized nutraceutical products to health food stores in America and internationally, and collaborates with universities in allergy and cancer research.
Found naturally in fruits and vegetables, D-Glucarate(TM) may enhance the body's capacity to resist many types of carcinogens and toxins. According to Thomas J. Slaga, Ph.D., Director of Cancer Cause and Prevention at the AMC Cancer Center in Denver, Colorado, ``There is strong scientific evidence that D-Glucarate(TM) prevents chemically induced cancers.'
Quest Vitamins joins Olympian Labs, Advanced Physicians Products, Country Life Vitamins, Highland Laboratories, Primary Source LLC, Pure Encapsulations, BioSynergy Nutraceuticals and others in adding the D-Glucarate(TM) technology to their product lines.
Nutraceutix, Inc. RN (http://www.nutraceutix.com/) develops, licenses and manufactures proprietary and non-proprietary private-label health supplements and related products for major health supplement companies, with distribution to health food retailers, multilevels, and mass merchants. Nutraceutix also manufactures products for major brands utilizing the proprietary processes of Controlled Delivery Technology (CDT(TM)), Molecular Dispersion Technology (MDT(TM)), LiveBac© probiotic caplets, BaCCine(TM), Bio-Tract(TM) BT2070, and the proprietary PureTab(TM) methodology, as well as health supplement products containing the patented compound Calcium D-Glucarate(TM). Nutraceutix's fermentation facility is located at corporate headquarters where it also conducts research and development for the continued development of new health supplements. Nutraceutix's private-label tableting, encapsulating and packaging facilities are located outside Boulder, Colorado.
Except for any historical information, the matters discussed in this press release contain forward-looking statements, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statement.
--------------------------------------------------------------------------------
Contact:
Nutraceutix
William St. John, 800/548-3222 or 425/883-9518 |
